Evidence map›Paper›PMID 41789065›Full record

ReviewFrontiers in immunology2026

The role of

Shaoju Qian, Siyu Li, Keyan Ye, Shuao Lu, Xiaoming Sha, Danqiong Zhang, Zhishan Xu, Xiangfeng Song, Ruixue Li

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shaoju QianSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.
Siyu LiSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.
Keyan YeSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.
Shuao LuSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.
Xiaoming ShaSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.
Danqiong ZhangSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.
Zhishan XuSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.
Xiangfeng SongSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, China.
Ruixue LiDepartment of Otolaryngology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With global viral emergence and increasing antiviral resistance, there is an urgent need for innovative immunomodulatory strategies. Gut microbiota modulation has gained attention as a promising therapeutic approach.

Indexed as

Clostridium butyricumGastrointestinal MicrobiomeImmunity, MucosalInflammationIntestinal MucosaVirus DiseasesAnimalsFatty Acids, VolatileHumansIntestinal Barrier FunctionProbioticsFatty Acids, Volatileantiviral effectsClostridium butyricumintestinal barriermucosal immunityrelieve inflammationshort-chain fatty acids

Identifiers

PMID41789065
PMCPMC12957134

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.